Ibogaine as a treatment for substance misuse: Potential benefits and practical dangers
- 1 January 2018
- book chapter
- Published by Elsevier
- Vol. 242, 217-257
Abstract
No abstract availableKeywords
This publication has 92 references indexed in Scilit:
- Effect of Iboga Alkaloids on µ-Opioid Receptor-Coupled G Protein ActivationPLOS ONE, 2013
- Anesthesia for Opiate Detoxification and the Ibogaine ControversyInternational Anesthesiology Clinics, 2011
- Ibogaine therapy in the treatment of opiate dependencyDrugs and Alcohol Today, 2010
- Polymorphism of Human Cytochrome P450 2D6 and Its Clinical SignificanceClinical Pharmacokinetics, 2009
- Liquid chromatography–electrospray mass spectrometry determination of ibogaine and noribogaine in human plasma and whole bloodApplication to a poisoning involving Tabernanthe iboga rootJournal of Chromatography B, 2006
- Ibogaine Therapy: A 'Vast, Uncontrolled Experiment'Science, 2005
- Ibogaine Produces Neurodegeneration in Rat, but Not Mouse, CerebellumAnnals of the New York Academy of Sciences, 1996
- Tissue distribution of ibogaine after intraperitoneal and subcutaneous administrationLife Sciences, 1996
- Identification of a primary metabolite of ibogaine that targets serotonin transporters and elevates serotoninLife Sciences, 1995
- The Total Synthesis of Iboga Alkaloids1Journal of the American Chemical Society, 1966